Osteoprotegerin in neuroprotection
Abstract:
Methods for treating neurodegeneration, e.g., sensorineural hearing loss, or a demyelinating disease, using bisphosphonates, ERK kinase inhibitors, and osteoprotegerin (OPG) proteins or nucleic acids.
Public/Granted literature
Information query
Patent Agency Ranking
0/0